Thrivent Financial For Lutherans Ascendis Pharma A/S Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 78,473 shares of ASND stock, worth $9.93 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

78,473

Previous 78,245 0.29%

Holding current value

$9.93 Million

Previous $10.7 Million 9.8%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$113.0 - $153.43 $25,764 - $34,982	228 Added 0.29%	78,473 $11.7 Million
Q2 2024 Aug 13, 2024	SELL	$121.07 - $153.67 $4.38 Million - $5.56 Million	-36,156 Reduced 31.6%	78,245 $10.7 Million
Q1 2024 May 14, 2024	BUY	$123.45 - $159.4 $140,362 - $181,237	1,137 Added 1.0%	114,401 $17.3 Million
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $188,559 - $278,918	-2,190 Reduced 1.9%	113,264 $14.3 Million
Q3 2023 Nov 14, 2023	BUY	$86.5 - $103.97 $129,923 - $156,162	1,502 Added 1.32%	115,454 $10.8 Million
Q2 2023 Aug 14, 2023	SELL	$69.96 - $97.84 $920,953 - $1.29 Million	-13,164 Reduced 10.36%	113,952 $10.2 Million
Q1 2023 May 17, 2023	BUY	$104.9 - $126.78 $201,198 - $243,164	1,918 Added 1.53%	127,116 $13.6 Million
Q4 2022 Feb 08, 2023	BUY	$99.42 - $131.97 $225,683 - $299,571	2,270 Added 1.85%	125,198 $15.3 Million
Q3 2022 Nov 14, 2022	SELL	$84.03 - $110.23 $1.1 Million - $1.44 Million	-13,051 Reduced 9.6%	122,928 $12.7 Million
Q2 2022 Aug 16, 2022	SELL	$78.08 - $117.61 $800,476 - $1.21 Million	-10,252 Reduced 7.01%	135,979 $12.6 Million
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $339,850 - $451,504	-3,326 Reduced 2.22%	146,231 $17.2 Million
Q4 2021 Feb 16, 2022	SELL	$127.1 - $169.66 $610,334 - $814,707	-4,802 Reduced 3.11%	149,557 $20.1 Million
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $2.84 Million - $4.47 Million	-25,244 Reduced 14.06%	154,359 $24.6 Million
Q2 2021 Aug 19, 2021	BUY	$121.62 - $145.29 $1.66 Million - $1.98 Million	13,642 Added 8.22%	179,603 $23.6 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $20.7 Million - $28.8 Million	165,961 New	165,961 $21.4 Million

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.06B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Ascendis Pharma A/S Transaction History